Coming soon

Prof. Michail Christodoulou was from 2021 an Assistant Professor and from 2024 an Associate Professor of Organic Chemistry in the Department of Food, Environmental and Nutritional Sciences of the University of Milan working on the synthesis of natural and synthetic compounds with antitumor, antifungal or antibacterial activity and in the development of novel green and sustainable enzymatic reactions.

Dr. Christodoulou received his BSc and MS from the Chemistry Department of the University of Patras, Greece, followed by a PhD in Medicinal Chemistry from the General Department of the Agricultural University of Athens, Greece, in 2010 with a thesis on the synthesis of novel bioactive molecules and evaluation of their biological activity. From 2011 till 2015 he worked as a postdoctoral researcher at the University of Milan, Italy, on the design and synthesis of natural and synthetic compounds focusing on different biological targets such as Cancer Stem Cells, the Glycocorticoid Receptor, Topoisomerase I and II, Sirtuins and Microtubules. From 2015 till 2017 he continued his research as a Post-Doctoral researcher at the University of Modena and Reggio Emilia, Italy, where he worked on the AIRC IG15993 project entitled: “Design and development of CDK2 and EGFR type III allosteric inhibitors as anticancer drugs”. From 2017 till 2020 he was an Assistant Professor at the Department of Pharmaceutical Sciences of the University of Milan working on the development of metal-catalysed and metal-free domino reactions and for the synthesis of novel compounds with anticancer activity. Dr. Christodoulou is author of 71 publications on international peer-reviewed journals and has presented his work at various international conferences in the field of cancer research. He is an active participant in the COST Actions: CA21145 “European Network for diagnosis and treatment of antibiotic-resistant bacterial infections (EURESTOP)”, CA21130 “P2X receptors as a therapeutic opportunity (PRESTO)” and CA22103 “A COMPREHENSIVE NETWORK AGAINST BRAIN CANCER (Net4Brain)”.